BARDA Industry Day Lightning Talk Selectees
BARDA is pleased to announce our selected Lightning Talk presenters for this year’s BARDA Industry Day. Due to interest and the number of excellent applications, there will be two Lightning Talks sessions this year.
Lightning Talks sessions beginning at 9:00am on Wednesday October 16th in the Grand Hyatt Declaration room:
|
Company |
Title |
|
CritiTech Particle Engineering Solutions |
Next-Gen Pulmonary MCMs Enabled by Supercritical Precipitation Technology |
|
DEINOVE |
DNV3837/DNV3681, a novel class of quinolonyl-oxazolidinone antibacterials targeting both urgent threats to public health and bioterrorism pathogens |
|
Dynocardia, Inc |
First, Standalone, Wearable Vital Signs Monitor for Controlling Emerging Infectious Diseases Outbreaks |
|
Fluid-Screen |
Fluid-Screen: Real-Time Microbial Detection for Biomanufacturing |
|
Foenestra Corporation |
Solid State Nanopore-Based Sequence Detection Platform |
|
Inflammatix, Inc. |
HostDx Endotypes: sepsis immunotherapy prediction |
|
Invirsa |
INV-102 Shows Unique Promise to Treat Ocular Sulfur Mustard Gas Injury |
|
KLOX Technologies Inc. |
Fluorescent Light Energy-Induced Biomodulation For The Management Of Burn Injuries: Acting At A Cellular Level To Control Inflammation And Improve Healing |
|
Myelo Therapeutics GmbH |
Myelo001 as an Orally Applied Treatment of Acute Radiation Syndrome |
|
Phagelux Inc. |
Field Deployable Bacteriophage Solutions for the Prevention and Treatment of Multidrug Resistant Infections |
|
Crossject |
Emergency needle free auto-injector |
Lightning Talks sessions beginning at 3:00pm on Wednesday October 16th in the Grand Hyatt Penn Quarter room:
|
Company |
Title |
|
CanaryQ |
Sample Handling for the Untrained User; No Mail-In Required |
|
DermiSense Inc |
Enabling the Presymptomatic Detection of Infection with Zero-Power Test Strips |
|
Karius, Inc. |
Karius Test Enabling Precision Medicine for Infectious Diseases |
|
RenovaCare, Inc. |
Stem Cell Therapies for Thermal, Chemical, & Radiation Burns |
|
Scanogen Inc. |
Point-of-care Molecular Detection of Bacterial Pathogens with Culture Level Sensitivity |
|
Terumo BCT |
Future Generation Pathogen Reduction Technology |
|
Univercells S.A. |
NevoLine Intensified, Integrated Vaccine Manufacturing Platform for MCM |
|
University of Notre Dame |
Phage-Mimicking, Broad-Spectrum, Antibacterial Nanoparticles |
|
Vaxxas |
Micro Array Patch for Pandemic Influenza Vaccine |